Lymphoma Hub
@lymphomahub
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia. linktr.ee/LymphomaHub_ #lymsm
ID: 1582593798
http://www.lymphomahub.com 10-07-2013 08:56:22
10,10K Tweet
10,10K Takipçi
2,2K Takip Edilen
CONGRESS | #EHA2025 | POSTER Carmelo Carlo-Stella Humanitas Milano shares updated safety run-in data from LOTIS-5, a phase 3, randomized trial of loncastuximab tesirine with rituximab (Lonca-R) vs immunochemotherapy in patients with R/R DLBCL/HGBL (N=20). ORR was achieved by 80%
